Form 4: DocuSign Director Marrs Sells Shares After RSU Vesting
Insider Transaction Report
DocuSign Director Anna Marrs reported the vesting of 725 restricted stock units and the subsequent sale of 363 common shares under a pre-arranged trading plan.
Summary
- Anna Marrs, a Director at DocuSign, acquired 725 shares of common stock on March 4, 2026, through the vesting of Restricted Stock Units (RSUs).
- On March 5, 2026, Marrs sold 363 shares of DocuSign common stock at a price of $46.33 per share.
- Both transactions were conducted under a Rule 10b5-1 trading plan, which allows insiders to pre-arrange stock trades to avoid accusations of insider trading.
- Following these transactions, Anna Marrs beneficially owns 12,251 shares of DocuSign common stock.
- The RSUs vest in twelve equal quarterly installments over three years, with a vesting commencement date of June 4, 2023.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral event. While a director selling shares can sometimes be seen negatively, the transaction is routine, pre-planned under a 10b5-1 plan, and likely for tax or liquidity purposes, not indicative of a change in company outlook.
Positives
- The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales and reducing concerns about opportunistic insider selling.
- The vesting of RSUs demonstrates the company's compensation structure for its directors, aligning their interests with long-term company performance.
Negatives
- A director selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, though it is often for tax purposes or personal liquidity.
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are common for executives and directors, often driven by tax obligations related to equity compensation or personal financial planning. The use of a Rule 10b5-1 plan is standard practice to mitigate concerns about trading on material non-public information.
Comparison to Industry Standards
- Insider sales following RSU vesting are a common occurrence across various industries, including technology. For example, similar patterns are observed at companies like Adobe (ADBE) or Salesforce (CRM) where executives periodically sell shares to cover tax liabilities or for diversification, typically under pre-arranged 10b5-1 plans.
- The sale of 363 shares out of 725 vested shares, leaving a substantial holding of 12,251 shares, is not unusual for a director managing their equity compensation.
Stakeholder Impact
- Shareholders: Minor impact, as it's a routine insider transaction. The director retains a significant stake.
- Employees: No direct impact.
Next Steps
- Continued vesting of remaining Restricted Stock Units in twelve equal quarterly installments over three years from June 4, 2023.
Key Dates
| Date | Description |
|---|---|
| June 4, 2023 | Vesting commencement date for Restricted Stock Units (RSUs). |
| March 4, 2026 | Acquisition of 725 common shares through RSU vesting. |
| March 5, 2026 | Sale of 363 common shares at $46.33 per share and filing date of the Form 4. |
Recommendation
holdThe filing details a routine insider transaction involving RSU vesting and a subsequent partial sale under a pre-arranged 10b5-1 plan. This type of transaction is common for directors and executives for tax management and personal liquidity and does not typically signal a change in the company's fundamental prospects or warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as this event alone does not provide new information to alter an existing investment position.
Keywords
DocuSign, DOCU, Anna Marrs, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, Stock Sale, Director, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.